Answers are grounded in this paper and cite their sources.
Identifying patients with cancer who are most at risk for VTE is essential to better target thromboprophylaxis, with the eventual goal of reducing the burden as well as the consequences of VTE for patients with cancer.
No takes yet. Share an insight, caveat, or question.
Khorana et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: